Mar 21, 2024 / 12:30PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to the Fennec Pharmaceuticals fourth-quarter and full year 2023 earnings and corporate update conference call. (Operator Instructions) As a reminder, today's conference is being recorded.
Now I would like to turn the conference over to Fennec's Chief Financial Officer, Robert Andrade. You may begin.
Robert Andrade - Fennec Pharmaceuticals Inc. - CFO
Thank you, operator, and good morning, everyone. We appreciate you joining us today for Fennec Pharmaceuticals' fourth quarter and full year 2023 earnings conference call, during which we will review our financial results as well as provide a general business update. Joining me from Fennec this morning are Rosty Raykov, our Chief Executive Officer, and Adrian Haigh, our Chief Operating Officer.
Before we begin, I would like to remind you that during this call the company will be making forward-looking statements that are subject to risks and uncertainties that may cause actual results to differ from the results discussed in the forward-looking
Q4 2023 Fennec Pharmaceuticals Inc Earnings Call Transcript
Mar 21, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers